Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Periostin Promotes Cell Proliferation and Macrophage Polarization to Drive Repair after AKI.

Kormann R, Kavvadas P, Placier S, Vandermeersch S, Dorison A, Dussaule JC, Chadjichristos CE, Prakoura N, Chatziantoniou C.

J Am Soc Nephrol. 2019 Nov 5. pii: ASN.2019020113. doi: 10.1681/ASN.2019020113. [Epub ahead of print]

PMID:
31690575
2.

The cannabinoid receptor 1 is involved in renal fibrosis during chronic allograft dysfunction: Proof of concept.

Dao M, Lecru L, Vandermeersch S, Ferreira M, Ferlicot S, Posseme K, Dürrbach A, Hermeziu B, Mussini C, Chatziantoniou C, François H.

J Cell Mol Med. 2019 Nov;23(11):7279-7288. doi: 10.1111/jcmm.14570. Epub 2019 Aug 30.

3.

Novel Targets for Therapy of Renal Fibrosis.

Prakoura N, Hadchouel J, Chatziantoniou C.

J Histochem Cytochem. 2019 Sep;67(9):701-715. doi: 10.1369/0022155419849386. Epub 2019 May 22.

PMID:
31116064
4.

MiR-21 is up-regulated in urinary exosomes of chronic kidney disease patients and after glomerular injury.

Lange T, Artelt N, Kindt F, Stracke S, Rettig R, Lendeckel U, Chadjichristos CE, Kavvadas P, Chatziantoniou C, Endlich K, Endlich N.

J Cell Mol Med. 2019 Jul;23(7):4839-4843. doi: 10.1111/jcmm.14317. Epub 2019 May 7. No abstract available.

5.

Novel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational study.

Alfieri C, Regalia A, Moroni G, Cresseri D, Zanoni F, Ikehata M, Simonini P, Rastaldi MP, Tripepi G, Zoccali C, Chatziantoniou C, Messa P.

J Nephrol. 2019 Feb;32(1):139-150. doi: 10.1007/s40620-018-00580-0. Epub 2019 Jan 10.

PMID:
30628019
6.

The family of 14-3-3 proteins and specifically 14-3-3σ are up-regulated during the development of renal pathologies.

Rizou M, Frangou EA, Marineli F, Prakoura N, Zoidakis J, Gakiopoulou H, Liapis G, Kavvadas P, Chatziantoniou C, Makridakis M, Vlahou A, Boletis J, Vlahakos D, Goumenos D, Daphnis E, Iatrou C, Charonis AS.

J Cell Mol Med. 2018 Sep;22(9):4139-4149. doi: 10.1111/jcmm.13691. Epub 2018 Jun 28.

7.

Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime.

Moll S, Yasui Y, Abed A, Murata T, Shimada H, Maeda A, Fukushima N, Kanamori M, Uhles S, Badi L, Cagarelli T, Formentini I, Drawnel F, Georges G, Bergauer T, Gasser R, Bonfil RD, Fridman R, Richter H, Funk J, Moeller MJ, Chatziantoniou C, Prunotto M.

J Transl Med. 2018 Jun 1;16(1):148. doi: 10.1186/s12967-018-1524-5.

8.

Notch3 orchestrates epithelial and inflammatory responses to promote acute kidney injury.

Kavvadas P, Keuylian Z, Prakoura N, Placier S, Dorison A, Chadjichristos CE, Dussaule JC, Chatziantoniou C.

Kidney Int. 2018 Jul;94(1):126-138. doi: 10.1016/j.kint.2018.01.031. Epub 2018 May 8.

PMID:
29751972
9.

The Role of Palladin in Podocytes.

Artelt N, Ludwig TA, Rogge H, Kavvadas P, Siegerist F, Blumenthal A, van den Brandt J, Otey CA, Bang ML, Amann K, Chadjichristos CE, Chatziantoniou C, Endlich K, Endlich N.

J Am Soc Nephrol. 2018 Jun;29(6):1662-1678. doi: 10.1681/ASN.2017091039. Epub 2018 May 2.

10.

Renal fibrosis: Recent translational aspects.

François H, Chatziantoniou C.

Matrix Biol. 2018 Aug;68-69:318-332. doi: 10.1016/j.matbio.2017.12.013. Epub 2017 Dec 30. Review.

PMID:
29292218
11.

Genetically increased angiotensin I-converting enzyme alters peripheral and renal vascular reactivity to angiotensin II and bradykinin in mice.

Chollet C, Placier S, Chatziantoniou C, Hus-Citharel A, Caron N, Roussel R, Alhenc-Gelas F, Bouby N.

Am J Physiol Heart Circ Physiol. 2018 Feb 1;314(2):H350-H358. doi: 10.1152/ajpheart.00356.2017. Epub 2017 Nov 3.

12.

Periostin in kidney diseases.

Prakoura N, Chatziantoniou C.

Cell Mol Life Sci. 2017 Dec;74(23):4315-4320. doi: 10.1007/s00018-017-2650-6. Epub 2017 Sep 7. Review.

PMID:
28884334
13.

The Role of Discoidin Domain Receptor 1 in Inflammation, Fibrosis and Renal Disease.

Dorison A, Dussaule JC, Chatziantoniou C.

Nephron. 2017;137(3):212-220. doi: 10.1159/000479119. Epub 2017 Jul 26. Review.

14.

Decreased Expression of Connexin 43 Blunts the Progression of Experimental GN.

Kavvadas P, Abed A, Poulain C, Authier F, Labéjof LP, Calmont A, Afieri C, Prakoura N, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

J Am Soc Nephrol. 2017 Oct;28(10):2915-2930. doi: 10.1681/ASN.2016111211. Epub 2017 Jun 30.

15.

Periostin and Discoidin Domain Receptor 1: New Biomarkers or Targets for Therapy of Renal Disease.

Prakoura N, Chatziantoniou C.

Front Med (Lausanne). 2017 May 9;4:52. doi: 10.3389/fmed.2017.00052. eCollection 2017. Review.

16.

NFκB-Induced Periostin Activates Integrin-β3 Signaling to Promote Renal Injury in GN.

Prakoura N, Kavvadas P, Kormann R, Dussaule JC, Chadjichristos CE, Chatziantoniou C.

J Am Soc Nephrol. 2017 May;28(5):1475-1490. doi: 10.1681/ASN.2016070709. Epub 2016 Dec 5.

17.

Loss of Notch3 Signaling in Vascular Smooth Muscle Cells Promotes Severe Heart Failure Upon Hypertension.

Ragot H, Monfort A, Baudet M, Azibani F, Fazal L, Merval R, Polidano E, Cohen-Solal A, Delcayre C, Vodovar N, Chatziantoniou C, Samuel JL.

Hypertension. 2016 Aug;68(2):392-400. doi: 10.1161/HYPERTENSIONAHA.116.07694. Epub 2016 Jun 13.

PMID:
27296994
18.

Extracorporeal shock wave therapy does not improve hypertensive nephropathy.

Caron J, Michel PA, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ.

Physiol Rep. 2016 Jun;4(11). pii: e12699. doi: 10.14814/phy2.12699.

19.

Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases.

Arvaniti E, Moulos P, Vakrakou A, Chatziantoniou C, Chadjichristos C, Kavvadas P, Charonis A, Politis PK.

Sci Rep. 2016 May 18;6:26235. doi: 10.1038/srep26235.

20.

Protective effects of genetic inhibition of Discoidin Domain Receptor 1 in experimental renal disease.

Kerroch M, Alfieri C, Dorison A, Boffa JJ, Chatziantoniou C, Dussaule JC.

Sci Rep. 2016 Feb 16;6:21262. doi: 10.1038/srep21262.

21.

Matrix Metalloproteinase-2 Knockout and Heterozygote Mice Are Protected from Hydronephrosis and Kidney Fibrosis after Unilateral Ureteral Obstruction.

Tveitarås MK, Skogstrand T, Leh S, Helle F, Iversen BM, Chatziantoniou C, Reed RK, Hultström M.

PLoS One. 2015 Dec 16;10(12):e0143390. doi: 10.1371/journal.pone.0143390. eCollection 2015.

22.

Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration.

Amador CA, Bertocchio JP, Andre-Gregoire G, Placier S, Duong Van Huyen JP, El Moghrabi S, Berger S, Warnock DG, Chatziantoniou C, Jaffe IZ, Rieu P, Jaisser F.

Kidney Int. 2016 Feb;89(2):354-62.

23.

Searching novel diagnostic markers and targets for therapy of CKD.

Kavvadas P, Dussaule JC, Chatziantoniou C.

Kidney Int Suppl (2011). 2014 Nov;4(1):53-57. Review.

24.

Discoidin domain receptor-1 and periostin: new players in chronic kidney disease.

Alfieri C, Kavvadas P, Simonini P, Ikehata M, Dussaule JC, Chadjichristos CE, Rastaldi MP, Messa P, Chatziantoniou C.

Nephrol Dial Transplant. 2015 Dec;30(12):1965-71. doi: 10.1093/ndt/gfv074. Epub 2015 Mar 31. Review.

25.

Cannabinoid receptor 1 is a major mediator of renal fibrosis.

Lecru L, Desterke C, Grassin-Delyle S, Chatziantoniou C, Vandermeersch S, Devocelle A, Vernochet A, Ivanovski N, Ledent C, Ferlicot S, Dalia M, Saïd M, Beaudreuil S, Charpentier B, Vazquez A, Giron-Michel J, Azzarone B, Durrbach A, François H.

Kidney Int. 2015 Jul;88(1):72-84. doi: 10.1038/ki.2015.63. Epub 2015 Mar 11.

26.

Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease.

El Machhour F, Keuylian Z, Kavvadas P, Dussaule JC, Chatziantoniou C.

J Am Soc Nephrol. 2015 Jul;26(7):1561-75. doi: 10.1681/ASN.2013090968. Epub 2014 Nov 24.

27.

A large neglected pleomorphic adenoma of the lung: Report of a rare case.

Gakidis I, Mihos PT, Chatziantoniou C, Stamatelopoulos A, Eftychiadis C, Mantas C.

Asian Cardiovasc Thorac Ann. 2014 Jun;22(5):620-2. doi: 10.1177/0218492313479959. Epub 2013 Oct 24.

PMID:
24867040
28.

Targeting connexin 43 protects against the progression of experimental chronic kidney disease in mice.

Abed A, Toubas J, Kavvadas P, Authier F, Cathelin D, Alfieri C, Boffa JJ, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

Kidney Int. 2014 Oct;86(4):768-79. doi: 10.1038/ki.2014.108. Epub 2014 May 21.

29.

Connexins in renal endothelial function and dysfunction.

Abed A, Dussaule JC, Boffa JJ, Chatziantoniou C, Chadjichristos CE.

Cardiovasc Hematol Disord Drug Targets. 2014;14(1):15-21. Review.

PMID:
24720461
30.

A low-cost, scalable technique to study distal coronary arteriole function.

Helle F, Dahl TD, Chatziantoniou C.

Acta Physiol (Oxf). 2014 Jun;211(2):260-7. doi: 10.1111/apha.12293. Epub 2014 Apr 23. No abstract available.

PMID:
24698112
31.

Inhibition of periostin expression protects against the development of renal inflammation and fibrosis.

Mael-Ainin M, Abed A, Conway SJ, Dussaule JC, Chatziantoniou C.

J Am Soc Nephrol. 2014 Aug;25(8):1724-36. doi: 10.1681/ASN.2013060664. Epub 2014 Feb 27.

32.

Transgelin Up-Regulation in Obstructive Nephropathy.

Karagianni F, Prakoura N, Kaltsa G, Politis P, Arvaniti E, Kaltezioti V, Psarras S, Pagakis S, Katsimboulas M, Abed A, Chatziantoniou C, Charonis A.

PLoS One. 2013 Jun 26;8(6):e66887. doi: 10.1371/journal.pone.0066887. Print 2013.

33.

Aldosterone mediates cardiac fibrosis in the setting of hypertension.

Azibani F, Fazal L, Chatziantoniou C, Samuel JL, Delcayre C.

Curr Hypertens Rep. 2013 Aug;15(4):395-400. doi: 10.1007/s11906-013-0354-3. Review.

PMID:
23686824
34.

Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents.

Kavvadas P, Weis L, Abed AB, Feldman DL, Dussaule JC, Chatziantoniou C.

Hypertension. 2013 Apr;61(4):901-7. doi: 10.1161/HYPERTENSIONAHA.111.00639. Epub 2013 Feb 25.

PMID:
23438929
35.

The RenTg mice: a powerful tool to study renin-dependent chronic kidney disease.

Huby AC, Kavvadas P, Alfieri C, Abed A, Toubas J, Rastaldi MP, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

PLoS One. 2012;7(12):e52362. doi: 10.1371/journal.pone.0052362. Epub 2012 Dec 26.

36.

Progression of renal fibrosis: the underestimated role of endothelial alterations.

Guerrot D, Dussaule JC, Kavvadas P, Boffa JJ, Chadjichristos CE, Chatziantoniou C.

Fibrogenesis Tissue Repair. 2012 Jun 6;5(Suppl 1):S15. doi: 10.1186/1755-1536-5-S1-S15. eCollection 2012.

37.

Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury.

Djudjaj S, Chatziantoniou C, Raffetseder U, Guerrot D, Dussaule JC, Boor P, Kerroch M, Hanssen L, Brandt S, Dittrich A, Ostendorf T, Floege J, Zhu C, Lindenmeyer M, Cohen CD, Mertens PR.

J Pathol. 2012 Nov;228(3):286-99. doi: 10.1002/path.4076. Epub 2012 Sep 7.

PMID:
22806125
38.

Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis.

Kerroch M, Guerrot D, Vandermeersch S, Placier S, Mesnard L, Jouanneau C, Rondeau E, Ronco P, Boffa JJ, Chatziantoniou C, Dussaule JC.

FASEB J. 2012 Oct;26(10):4079-91. doi: 10.1096/fj.11-194902. Epub 2012 Jul 2.

PMID:
22751008
39.

[Hypertension-induced fibrosis: a balance story].

Azibani F, Fazal L, Chatziantoniou C, Samuel JL, Delcayre C.

Ann Cardiol Angeiol (Paris). 2012 Jun;61(3):150-5. doi: 10.1016/j.ancard.2012.05.004. Epub 2012 May 25. French.

PMID:
22681982
40.

Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice.

Azibani F, Devaux Y, Coutance G, Schlossarek S, Polidano E, Fazal L, Merval R, Carrier L, Solal AC, Chatziantoniou C, Launay JM, Samuel JL, Delcayre C.

PLoS One. 2012;7(5):e38197. doi: 10.1371/journal.pone.0038197. Epub 2012 May 30.

41.

Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.

Azibani F, Benard L, Schlossarek S, Merval R, Tournoux F, Fazal L, Polidano E, Launay JM, Carrier L, Chatziantoniou C, Samuel JL, Delcayre C.

Hypertension. 2012 Jun;59(6):1179-87. doi: 10.1161/HYPERTENSIONAHA.111.190512. Epub 2012 Apr 30.

PMID:
22547442
42.

Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction.

Bige N, Shweke N, Benhassine S, Jouanneau C, Vandermeersch S, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ.

Kidney Int. 2012 Jun;81(12):1226-38. doi: 10.1038/ki.2012.21. Epub 2012 Mar 14.

43.

Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy.

Guerrot D, Dussaule JC, Mael-Ainin M, Xu-Dubois YC, Rondeau E, Chatziantoniou C, Placier S.

PLoS One. 2012;7(3):e31974. doi: 10.1371/journal.pone.0031974. Epub 2012 Mar 5.

44.

[Chronic kidney disease, new therapeutic approaches].

Boffa JJ, Dussaule JC, Ronco P, Chatziantoniou C.

Rev Prat. 2012 Jan;62(1):72-5. French.

PMID:
22335071
45.

Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy.

Guerrot D, Kerroch M, Placier S, Vandermeersch S, Trivin C, Mael-Ainin M, Chatziantoniou C, Dussaule JC.

Am J Pathol. 2011 Jul;179(1):83-91. doi: 10.1016/j.ajpath.2011.03.023. Epub 2011 May 13.

46.

Notch3 is essential for regulation of the renal vascular tone.

Boulos N, Helle F, Dussaule JC, Placier S, Milliez P, Djudjaj S, Guerrot D, Joutel A, Ronco P, Boffa JJ, Chatziantoniou C.

Hypertension. 2011 Jun;57(6):1176-82. doi: 10.1161/HYPERTENSIONAHA.111.170746. Epub 2011 Apr 25.

PMID:
21518968
47.

Alteration of connexin expression is an early signal for chronic kidney disease.

Toubas J, Beck S, Pageaud AL, Huby AC, Mael-Ainin M, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

Am J Physiol Renal Physiol. 2011 Jul;301(1):F24-32. doi: 10.1152/ajprenal.00255.2010. Epub 2011 Mar 23.

48.

The role of cell plasticity in progression and reversal of renal fibrosis.

Dussaule JC, Guerrot D, Huby AC, Chadjichristos C, Shweke N, Boffa JJ, Chatziantoniou C.

Int J Exp Pathol. 2011 Jun;92(3):151-7. doi: 10.1111/j.1365-2613.2011.00760.x. Epub 2011 Feb 12. Review.

49.

Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis.

Mihout F, Shweke N, Bigé N, Jouanneau C, Dussaule JC, Ronco P, Chatziantoniou C, Boffa JJ.

J Pathol. 2011 Jan;223(1):37-45. doi: 10.1002/path.2769. Epub 2010 Sep 15.

PMID:
20845411
50.

[Role of cell plasticity in progression and regression of renal fibrosis].

Dussaule JC, Guerrot D, Huby AC, Boffa JJ, Chatziantoniou C.

Bull Acad Natl Med. 2009 Dec;193(9):1993-2003; discussion 2003-4. French.

PMID:
20666013

Supplemental Content

Loading ...
Support Center